Product logins

Find logins to all Clarivate products below.


Sara Al-Zubeidi

Director, Commercial Strategy Consulting Global Pricing and Market Access

Sara Al-Zubeidi is a Director with Clarivate based in London. Sara has 7+ years commercial strategy consulting experience in life sciences, specializing in global pricing and market access.

Sara leads teams for global P&MA engagements on behalf of pharmaceutical and biotechnology companies. Areas of expertise include pricing and access strategy, evidence generation for HTA submission, innovative agreement strategy, HTA landscape analysis, analogue assessments, value proposition/story development and payer objection handling/negotiation tactics. She also has extensive experience in commercial opportunity assessments, including indication and opportunity prioritization and patient flow assessments. Sara has deep expertise across a wide span of therapeutic areas with oncology, orphan/rare diseases, cardiology, renal and metabolic diseases as specialist areas of interest.

Prior to joining consulting, Sara worked in business development specifically for HEOR and Evidence Strategy teams.

Sara has a Master’s degree in Pharmacogenetics and Stratified Medicine at University College of London (UCL) and a BSc (Hons) in Medical Genetics from Queen Mary University of London.

Latest news

News May 6, 2026
Clarivate launches Web of Science Research Intelligence

AI-native research intelligence platform for research funding, strategy and impact now available globally to institutions LONDON, UK — May 6, 2026: Clarivate Plc (NYSE: CLVT), a leading global provider of…

News April 29, 2026
Clarivate Reports First Quarter 2026 Results

— Value Creation Plan delivering accelerated organic revenue growth — — Utilized solid free cash flow generation to deleverage — — Reaffirms 2026 financial outlook — London, UK — April…

News April 28, 2026
Clarivate Introduces Nexus Connect, the First Institutional AI Gateway to Trusted Research and Learning

Nexus Connect provides a single, university-branded connector inside AI chat agents, giving students and researchers seamless access to scholarly resources and services. LONDON, UK — April 28, 2026: Clarivate Plc…

Related resources

How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center